Case File
efta-efta01895294DOJ Data Set 10CorrespondenceEFTA Document EFTA01895294
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01895294
Pages
0
Persons
0
Integrity
No Hash Available
Loading PDF viewer...
Extracted Text (OCR)
EFTA DisclosureText extracted via OCR from the original document. May contain errors from the scanning process.
To:
Jeffrey [email protected]]
From:
David Stern
Sent:
Thur 4/18/2013 1:49:18 PM
Subject: Re: Proposed SC investment framework - for discussion
I am meeting them tomorrow at 4pm UK time.
Any tweaking help from you is greatly appreciated !!!
On 18 Apr 2013, at 13:23, Jeffrey Epstein wrote:
thoughtful proposal , with a Ittle tweaking not bad
On Thu, Apr IS, 2013 at 7:55 AM, David Stem <a
wrote:
Please let me know your views.
Thanks!
Begin forwarded message:
From: Ramesh Venkataraman
Subject: Proposed SC investment framework - for
discussion
Date: 13 April 2013 21:17:07 GMT+01:00
To: '
David,
Hope your trip to China is going well. Apologies that it has taken me a
week to follow up on our discussions. Have been swamped on a number
of fronts including an unexpected (but hopefully positive) turn of events
on Poseidon — will brief you on your return from China.
Here is a proposed framework that I have developed for your
review/comment. Let me have your thoughts either via email or, if you
prefer, we can wait until your return to discuss in person.
1.
Subject to confirmatory diligence (expected to take no more
than 2-3 weeks) and final documentation, SC will invest $5 million
in July 2013 or as soon as AG receives the first RMB 1 mn from
Chengdu. As discussed, this $5 million amount will be the only
funding commitment from SC to AG (and this should be
documented and minuted by AG for the avoidance of
doubt/misconception). However, as discussed, we are fully
EFTA_R1_00318893
EFTA01895294
committed to assisting you/AG in future rounds of capital raising
from other investors including tapping the Samena network.
2.
Our instrument will be structured as preference shares (zero
coupon) convertible into common equity upon a liquidity event
(IPO, trade sale, partial divestment).
3.
Our instrument will presumably rank behind the Informa $16
mn loan note from 2010 (payable in 2020 with a 10% roll up
coupon) and only be payable after that loan note principal and
accrued interest are paid out. We can refine our structure once
we have access to the loan note docs and understand the draw
down schedule and payment obligations.
4.
The conversion ratio for our instrument into equity shares
will be on the basis of a liquidity preference table as follows:
A. If a liquidity event happens before the next capital raising
round or 18 months from the date of our
investment (whichever is earlier): our instrument earns a
fixed IRR of 50%. The idea here is to give you and the current
management team disproportionate 'credit' for the liquidity
event if it is achieved relatively quickly after we invest. To
explain by way of an illustration, if AG is sold in 12 months at
an Enterprise Value (EV) of, say, $50 mn then the payment
waterfall is as follows:
a.
Informa - $16 mn plus accrued interest, say,
$5mn = $21 mn
b. SC - $7.5 mn (50% IRR for 12 months on $5 mn
investment)
c.
Balance $21.5 mn to be split across the remaining
common equity holders in proportion to their
shareholding %
B. If a liquidity event happens after the next capital raising
round or the 18 month anniversary of the date of the SC
investment:
Exit EV
Samena % of exit
'waterfall'
proceeds
3m
0 to 100
50%
100 to 500
20%
500 plus
10%
The way to read this is as follows — 'if the EV at exit is $50 mn,
then Samena will get 50% of the amount over that owed to
Informa. If the Informa loan note principal + accrued interest
EFTA_R1_00318894
EFTA01895295
repayment obligation is $24 mn, then Samena gets $13 mn and
the other common equity holders get $13 mn. If the EV at exit is
$120 mn, then SC gets $42 mn (50% of $76 mn plus 20% of $20
mn). If the exit is at a blockbuster EV of $500M, SC gets $118M
and the other equity holders collectively get $358 mn, with the
balance $24 mn of course being payable to Informa.
5.
Any new investor in a subsequent round (say in 2014) buys
into the equity in a normal way, ie, the board sets a pre-money
valuation for the equity etc. The SC prefs do not get diluted — ie,
the conversion framework outlined above stays the same.
6.
Other terms can be worked out, eg, negative covenants,
board seats, IPO secondary offering rights, etc. It is also going to
be critical to discuss how AG's burn rate can be reduced — ideally
cut below $700K p.m., so our investment plus the $6M of cash
that AG has currently can last at least 18 months just in case of
the inevitable execution delays in Chengdu.
David, please treat this as a draft for discussion that we can refine over
the next few days based on your feedback to arrive at a mutually
acceptable framework.
Best
Ramesh
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by c-mail to jcevacationrii umail corn, and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA_R1_00318895
EFTA01895296
Related Documents (6)
DOJ Data Set 11OtherUnknown
EFTA02421891
1p
DOJ Data Set 10CorrespondenceUnknown
EFTA Document EFTA01726449
0p
DOJ Data Set 11OtherUnknown
EFTA02542466
2p
DOJ Data Set 10CorrespondenceUnknown
EFTA Document EFTA02148553
0p
DOJ Data Set 10CorrespondenceUnknown
EFTA Document EFTA01719107
0p
DOJ Data Set 10CorrespondenceUnknown
EFTA Document EFTA01751001
0p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.